title: [Blueprint for the development of remyelination medicines for multiple sclerosis].
authors.affiliation: Center for Integrated Medical Research & Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
authors.forename: Jin
authors.initials: J
authors.lastname: Nakahara
mesh_terms: D000123:Acetyltransferases / Q000037:antagonists & inhibitors; D000906:Antibodies / Q000627:therapeutic use; D001921:Brain / Q000166:cytology / Q000502:physiology; D002454:Cell Differentiation / Q000235:genetics; D002908:Chronic Disease; D006801:Humans; D008055:Lipids; D058990:Molecular Targeted Therapy; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D009186:Myelin Sheath / Q000502:physiology*; D009416:Nerve Regeneration / Q000502:physiology*; D009836:Oligodendroglia / Q000166:cytology*; D017452:Receptors, IgG / Q000276:immunology / Q000502:physiology; D014157:Transcription Factors / Q000037:antagonists & inhibitors
chemical_list: D000906:Antibodies; D008055:Lipids; D017452:Receptors, IgG; D014157:Transcription Factors; D000123:Acetyltransferases; C111246:HTATIP2 protein, human